Reciprocal functions of hepatocyte growth factor and transforming growth factor-β1 in the progression of renal diseases: A role for CD44?

Kidney International, Supplement

Volumn 64, Issue 86, 2003, Pages

  Florquin, Sandrine ^a,b   Rouschop, Kasper M A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; GLYCOPROTEIN; HERMES ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA;

ANTIGEN ANTIBODY COMPLEX; CELL INFILTRATION; COMPLEMENT FACTOR; CONFERENCE PAPER; DISEASE COURSE; EXTRACELLULAR MATRIX; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; KIDNEY INJURY; MACROPHAGE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; URETER OBSTRUCTION; ANIMAL; HUMAN; METABOLISM; PATHOPHYSIOLOGY; REVIEW;

ANIMALS; ANTIGENS, CD44; DISEASE PROGRESSION; HEPATOCYTE GROWTH FACTOR; HUMANS; KIDNEY DISEASES; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 0141426705     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.64.s86.4.x     Document Type: Conference Paper

References (57)

1. KLAHR S, MORRISSEY J: Obstructive nephropathy and renal fibrosis. Am J Physiol Renal Physiol 283:F861-875, 2002
2. EDDY AA: Molecular basis of renal fibrosis. Pediatr Nephrol 15:290-301, 2000
3. NANGAKU M, PIPPIN J, COUSER WG: C6 mediates chronic progression of tubulointerstitial damage in rats with remnant kidneys. J Am Soc Nephrol 13:928-936, 2002
4. VAN KOOTEN C, DAHA MR: Cytokine cross-talk between tubular epithelial cells and interstitial immunocompetent cells. Curr Opin Nephrol Hypertens 10:55-59, 2001
5. SHAPPELL SB, MENDOZA LH, GURPINAR T, et al: Expression of adhesion molecules in kidney with experimental chronic obstructive uropathy: The pathogenic role of ICAM-1 and VCAM-1. Nephron 85:156-166, 2000
6. NIKOLIC-PATERSON DJ, LAN HY, ATKINS RC: Macrophages in immune renal injury, in Immunologic Renal Diseases, 2nd edition, Philadelphia, Lippincott Williams & Wilkins, edited by NEILSON E, COUSER W, 2001, pp 609-632
7. NIKOLIC-PATERSON DJ, ATKINS RC: The role of macrophages in glomerulonephritis. Nephrol Dial Transplant 16:3-7, 2001
8. KANG DH, ANDERSON S, KIM YG, et al: Impaired angiogenesis in the aging kidney: Vascular endothelial growth factor and thrombospondin-1 in renal disease. Am J Kidney Dis 37:601-611, 2001
9. KANG DH, KANELLIS J, HUGO C, et al: Role of the microvascular endothelium in progressive renal disease. J Am Soc Nephrol 13:806-816, 2002
10. IWANO M, PLIETH D, DANOFF TM, et al: Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110:341-350, 2002
11. STRUTZ F, OKADA H, LO CW, et al: Identification and characterization of a fibroblast marker: FSP1. J Cell Biol 130:393-405, 1995
12. LENZ O, ELLIOT SJ, STETLER-STEVENSON WG: Matrix metalloproteinases in renal development and disease. J Am Soc Nephrol 11:574-581, 2000
13. STAHL PJ, FELSEN D: Transforming growth factor-beta, basement membrane, and epithelial-mesenchymal transdifferentiation: Implications for fibrosis in kidney disease. Am J Pathol 159:1187-1192, 2001
14. LIU Y: Hepatocyte growth factor and the kidney. Curr Opin Nephrol Hypertens 11:23-30, 2002
15. LIU Y, TOLBERT EM, SUN AM, DWORKIN LD: Primary structure of rat HGF receptor and induced expression in glomerular mesangial cells. Am J Physiol 271:F679-688, 1996
16. ABBATE M, ZOJA C, ROTTOLI D, et al: Proximal tubular cells promote fibrogenesis by TGF-beta1-mediated induction of peritubular myofibroblasts. Kidney Int 61:2066-2077, 2002
17. YU Q, STAMENKOVIC I: Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 14:163-176, 2000
18. CRAWFORD SE, STELLMACH V, MURPHY-ULLRICH JE, et al: Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Cell 93:1159-1170, 1998
19. CHU TM, KAWINSKI E: Plasmin, substilisin-like endoproteases, tissue plasminogen activator, and urokinase plasminogen activator are involved in activation of latent TGF-beta 1 in human seminal plasma. Biochem Biophys Res Commun 253:128-134, 1998
20. MATSUMOTO K, OKAZAKI H, NAKAMURA T: Up-regulation of hepatocyte growth factor gene expression by interleukin-1 in human skin fibroblasts. Biochem Biophys Res Commun 188:235-243, 1992
21. MATSUMOTO K, NAKAMURA T: Heparin functions as a hepatotrophic factor by inducing production of hepatocyte growth factor. Biochem Biophys Res Commun 227:455-461, 1996
22. WENG J, MOHAN RR, LI Q, WILSON SE: IL-1 upregulates keratinocyte growth factor and hepatocyte growth factor mRNA and protein production by cultured stromal fibroblast cells: Interleukin-1 beta expression in the cornea. Cornea 16:465-471, 1997
23. MIZUNO S, MATSUMOTO K, KUROSAWA T, et al: Reciprocal balance of hepatocyte growth factor and transforming growth factor-beta 1 in renal fibrosis in mice. Kidney Int 57:937-948, 2000
24. YANG J, DAI C, LIU Y: Systemic administration of naked plasmid encoding hepatocyte growth factor ameliorates chronic renal fibrosis in mice. Gene Ther 8:1470-1479, 2001
25. LIU Y, RAJUR K, TOLBERT E, DWORKIN LD: Endogenous hepatocyte growth factor ameliorates chronic renal injury by activating matrix degradation pathways. Kidney Int 58:2028-2043, 2000
26. KAWAIDA K, MATSUMOTO K, SHIMAZU H, NAKAMURA T: Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice. Proc Natl Acad Sci USA 91:4357-4361, 1994
27. WRIGHT EJ, MCCAFFREY TA, ROBERTSON AP, et al: Chronic unilateral ureteral obstruction is associated with interstitial fibrosis and tubular expression of transforming growth factor-beta. Lab Invest 74:528-537, 1996
28. SCHIFFER M, VON GERSDORFF G, BITZER M, et al: Smad proteins and transforming growth factor-beta signaling. Kidney Int Suppl 77:S45-52, 2000
29. WAHL SM: TGF-beta in the evolution and resolution of inflammatory and immune processes. Introduction. Microbes Infect 1:1247-1249, 1999
30. WANG SN, LAPAGE J, HIRSCHBERG R: Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy. Kidney Int 57:1002-1014, 2000
31. GAO X, MAE H, AYABE N, et al: Hepatocyte growth factor gene therapy retards the progression of chronic obstructive nephropathy. Kidney Int 62:1238-1248, 2002
32. MIYAJIMA A, CHEN J, LAWRENCE C, et al: Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction. Kidney Int 58:2301-2313, 2000
33. MILLER SB, MARTIN DR, KISSANE J, HAMMERMAN MR: Hepatocyte growth factor accelerates recovery from acute ischemic renal injury in rats. Am J Physiol 266:F129-134, 1994
34. VIJAYAN A, MARTIN DR, SADOW JL, et al: Hepatocyte growth factor inhibits apoptosis after ischemic renal injury in rats. Am J Kidney Dis 38:274-278, 2001
35. LIU Y: Hepatocyte growth factor promotes renal epithelial cell survival by dual mechanisms. Am J Physiol 277:F624-633, 1999
36. MIZUNO S, MATSUMOTO K, NAKAMURA T: Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy. Kidney Int 59:1304-1314, 2001
37. YANG J, DAI C, LIU Y: Hepatocyte growth factor gene therapy and angiotensin II blockade synergistically attenuate renal interstitial fibrosis in mice. J Am Soc Nephrol 13:2464-2477, 2002
38. YANG J, LIU Y: Delayed administration of hepatocyte growth factor reduces renal fibrosis in obstructive nephropathy. Am J Physiol Renal Physiol 284:F349-357, 2003
39. ISAKA Y, TSUJIE M, ANDO Y, et al: Transforming growth factor-beta 1 antisense oligodeoxynucleotides block interstitial fibrosis in unilateral ureteral obstruction. Kidney Int 58:1885-1892, 2000
40. INOUE T, OKADA H, KOBAYASHI T, et al: Hepatocyte growth factor counteracts transforming growth factor-beta1, through attenuation of connective tissue growth factor induction, and prevents renal fibrogenesis in 5/6 nephrectomized mice. FASEB J 17:268-270, 2003
41. INOUE T, OKADA H, KOBAYASHI T, et al: TGF-beta1 and HGF coordinately facilitate collagen turnover in subepithelial mesenchyme. Biochem Biophys Res Commun 297:255-260, 2002
42. BENZ PS, FAN X, WUTHRICH RP: Enhanced tubular epithelial CD44 expression in MRL-lpr lupus nephritis. Kidney Int 50:156-163, 1996
43. GRIFFIOEN AW, COENEN MJ, DAMEN CA, et al: CD44 is involved in tumor angiogenesis; an activation antigen on human endothelial cells. Blood 90:1150-1159, 1997
44. GUNTHERT U: CD44: A multitude of isoforms with diverse functions. Curr Top Microbiol Immunol 184:47-63, 1993
45. LESLEY J, HYMAN R, KINCADE PW: CD44 and its interaction with extracellular matrix. Adv Immunol 54:271-335, 1993
46. SIEGELMAN MH, DEGRENDELE HC, ESTESS P: Activation and interaction of CD44 and hyaluronan in immunological systems. J Leukoc Biol 66:315-321, 1999
47. TANAKA Y, ADAMS DH, HUBSCHER S, et al: T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1 beta. Nature 361:79-82, 1993
48. JACKSON DG, BELL JI, DICKINSON R, et al: Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon. J Cell Biol 128:673-685, 1995
49. VAN DER VOORT R, KEEHNEN RM, BEULING EA, et al: Regulation of cytokine signaling by B cell antigen receptor and CD40-controlled expression of heparan sulfate proteoglycans. J Exp Med 192:1115-1124, 2000
50. VAN DER VOORT R, TAHER TE, WIELENGA VJ, et al: Heparan sulfate-modified CD44 promotes hepatocyte growth factor/scatter factor-induced signal transduction through the receptor tyrosine kinase c-Met. J Biol Chem 274:6499-6506, 1999
51. BOURGUIGNON LY, SINGLETON PA, ZHU H, ZHOU B: Hyaluronan promotes signaling interaction between CD44 and the TGF-β RI in metastatic breast tumor cells. J Biol Chem 277:39703-39712, 2002
52. TAKAZOE K, FOTI R, TESCH GH, et al: Up-regulation of the tumour-associated marker CD44V6 in experimental kidney disease. Clin Exp Immunol 121:523-532, 2000
53. FLORQUIN S, NUNZIATA R, CLAESSEN N, et al: CD44 expression in IgA nephropathy. Am J Kidney Dis 39:407-414, 2002
54. SCREATON GR, BELL MV, JACKSON DG, et al: Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 89:12160-12164, 1992
55. DOUGHERTY GJ, LANDORP PM, COOPER DL, HUMPHRIES RK: Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte "homing" receptor expressed by hemopoietic cells. J Exp Med 174:1-5, 1991
56. TOLG C, HOFMANN M, HERRLICH P, PONTA H: Splicing choice from ten variant exons establishes CD44 variability. Nucleic Acids Res 21:1225-1229, 1993
57. ROUSCHOP KMA, SEWNATH ME, CLAESSEN N, et al: CD44 protects kidneys in vivo from tubular damage but promotes fibrosis through alteration of HGF/cMet and TGF-β1 signaling pathways. J Am Soc Nephrol 13:162A, 2002